Advances in understanding and treatment of immune‐mediated disorders of the peripheral nervous system
- 15 July 2004
- journal article
- review article
- Published by Wiley in Muscle & Nerve
- Vol. 30 (2), 131-156
- https://doi.org/10.1002/mus.20076
Abstract
During recent years, novel insights in basic immunology and advances in biotechnology have contributed to an increased understanding of the pathogenetic mechanisms of immune‐mediated disorders of the peripheral nervous system. This increased knowledge has an impact on the management of patients with this class of disorders. Current advances are outlined and their implication for therapeutic approaches addressed. As a prototypic immune‐mediated neuropathy, special emphasis is placed on the pathogenesis and treatment of the Guillain–Barré syndrome and its variants. Moreover, neuropathies of the chronic inflammatory demyelinating, multifocal motor, and nonsystemic vasculitic types are discussed. This review summarizes recent progress with currently available therapies and—on the basis of present immunopathogenetic concepts—outlines future treatment strategies. Muscle Nerve 30: 131–136, 2004This publication has 278 references indexed in Scilit:
- Efficacy and safety of rituximab in type II mixed cryoglobulinemiaBlood, 2003
- Anterior interosseous nerve and multifocal motor neuropathyMuscle & Nerve, 2002
- Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathyAnnals of Neurology, 2001
- Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodiesBrain, 1995
- Intravenous Immunoglobulins Suppress Immunoglobulin Productions by Suppressing Ca2+ ‐Dependent Signal Transduction Through Fc γ Receptors in B LymphocytesScandinavian Journal of Immunology, 1994
- Axonal Guillain–Barré syndromeMuscle & Nerve, 1994
- Endothelial cell activation in vasculitis of peripheral nerve and skeletal muscle.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Gangliosides of human melanomaCancer, 1989
- Plasma Exchange in Chronic Inflammatory Demyelinating PolyradiculoneuropathyThe New England Journal of Medicine, 1986
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981